With 0.63 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.45 million shares. The 52-week range on CRCT shows that it touched its highest point at $7.20 and its lowest point at $3.94 during that stretch. It currently has a 1-year price target of $4.10. With its current market cap of 1.32 billion, CRCT has annualized dividend of $0.20 while the current yield stands at 3.20%. Beta for the stock currently stands at 0.03.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CRCT was up-trending over the past week, with a rise of 23.03%, but this was up by 28.87% over a month. Three-month performance surged to 12.41% while six-month performance rose 12.21%. The stock lost -17.26% in the past year, while it has gained 9.65% so far this year. A look at the trailing 12-month EPS for CRCT yields 0.31 with Next year EPS estimates of 0.23. For the next quarter, that number is 0.06. This implies an EPS growth rate of -18.85% for this year and -3.85% for next year. EPS is expected to decline by -4.61% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -52.55%.
Float and Shares Shorts:
At present, 51.63 million CRCT shares are outstanding with a float of 42.64 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CRCT since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.28361 being high and $0.27565 being low. For CRCT, this leads to a yearly average estimate of $0.27964. Based on analyst estimates, the high estimate for the next quarter is $0.05 and the low estimate is $0.03. The average estimate for the next quarter is thus $0.04.
